Evoke Pharma to Present at the Upcoming Roth and Oppenheimer Investor Conferences
Mar 06, 2018 12:31 pm UTC| Business
SOLANA BEACH, Calif., March 06, 2018 -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that Dave Gonyer, President and...
Mar 06, 2018 12:31 pm UTC| Business
Post-hoc analysis demonstrates potential of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) to provide effective pain relief regardless of prior intra-articular corticosteroid useEffects of...
KemPharm to Present at Upcoming Investor Conferences
Mar 06, 2018 12:31 pm UTC| Business
Presentations to Highlight Corporate and Clinical Progress CORALVILLE, Iowa, March 06, 2018 -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary...
Mar 06, 2018 12:31 pm UTC| Business
NEW YORK, March 06, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of People's United...
Mar 06, 2018 12:31 pm UTC| Business
DUBLIN, Ireland and TREVOSE, Pa., March 06, 2018 -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare...
Mar 06, 2018 12:31 pm UTC| Business
FT. LAUDERDALE, Fla., March 06, 2018 -- Netsurion, a leading provider of managed network connectivity, security, and compliance solutions, today announced the launch of Netsurion Connect, its software-defined wide-area...
Mar 06, 2018 12:31 pm UTC| Business
BOSTON, March 06, 2018 -- Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced it will webcast its corporate...